SG/PUT/CVS HEALTH/100/0.1/21.06.24 Stock

Warrant

DE000SQ6LAF2

Market Closed - Deutsche Boerse AG 03:36:44 2024-05-31 pm EDT
3.78 EUR -6.90% Intraday chart for SG/PUT/CVS HEALTH/100/0.1/21.06.24
1 month+26.42%
3 months+58.82%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-31 3.78 -6.90%
24-05-30 4.06 -5.36%
24-05-29 4.29 +0.94%
24-05-28 4.25 +5.72%
24-05-27 4.02 -1.47%

Delayed Quote Deutsche Boerse AG

Last update May 31, 2024 at 03:36 pm EDT

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying CVS HEALTH CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ6LAF
ISINDE000SQ6LAF2
Date issued 2022-12-20
Strike 100 $
Maturity 2024-06-21 (20 Days)
Parity 10 : 1
Emission price 1.3
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 4.33
Lowest since issue 1.27
Delta-0.94x
Omega 1.378
Premium0.21x
Gearing1.47x
Moneyness 1.678
Difference Strike 40.4 $
Difference Strike %+40.40%
Spread 0.01
Spread %0.27%
Intrinsic value 3.724

Company Profile

CVS Health Corporation is one of the leading American suppliers of health products and services. Net sales (including intragroup) break down by activity as follows: - medical insurance plan management services (45.6%; Pharmacy Benefit Management): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - retail distribution (28.5%): sale of prescription pharmaceutical products, OTC products, beauty and cosmetics products. At the end of 2023, products are marketed primarily via a network of more than 9,000 outlets and via the Internet. In addition, the group offers healthcare services through more than 1,000 clinics (MinuteClinic®); - medical benefits management (25.8%); - other (0.1%).
Sector
-
More about the company

Ratings for CVS Health Corporation

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: CVS Health Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
59.6 USD
Average target price
70.17 USD
Spread / Average Target
+17.73%
Consensus